NDC 51660-567 – Guaifenesin
Guaifenesin 1200 mg/1 · Tablet, Extended Release · Oral
Product NDC51660-567
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- Ohm Laboratories, Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA209254
- Marketed since
- April 1, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 1200 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 51660-567-54 | 14 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-54) | Apr 1, 2022 |
| 51660-567-58 | 56 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-58) | Apr 1, 2022 |
| 51660-567-86 | 28 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-86) | Apr 1, 2022 |
Other Guaifenesin products
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 58602-865 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-853 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-857 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-811 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-864 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-810 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 21130-179 Guaifenesin 600 mg/1 · Tablet, Extended Release · Better Living Brands LLC
- 68001-561 Guaifenesin 600 mg/1 · Tablet, Extended Release · BluePoint Laboratories